pharma
Independent research may change the immunotherapy game
August 17, 2017Research and Development Cancer, biotech, drugs, immunotherapy, pharma, pharmaceutical
Immunotherapy treatments that focus on the PD-L1 protein have become some of the most exciting to emerge in cancer treatment. …
FDA recalls liquid pharma products after bacterial contamination detected
August 17, 2017Medical Communications, Sales and Marketing FDA, life sciences, pharma, pharmaceutical
The FDA has announced that it has been forced to recall a range of liquid pharmaceutical and dietary supplement products …
Alexion moves to bolster patent protection of Soliris
August 17, 2017Sales and Marketing Alexion, biotech, drugs, pharma, pharmaceutical, soliris
Soliris brought in net sales of $2.8 billion last year for Alexion, meaning it accounted for close to 90% of …
Novo diabetes drug outperforms Lilly rival at Phase 3
August 17, 2017Research and Development Eli Lilly, Novo Nordisk, diabetes, life sciences, medicine, pharma, pharmaceutical, type 2 diabetes
Novo Nordisk has revealed that its diabetes drug semaglutide managed to outperform Eli Lilly’s own treatment dulaglutide (Trulicity) in controlling …
Cancer Research UK and NU agree three-year research Astex Pharma deal
August 17, 2017Research and Development, Sales and Marketing Astex pharmaceuticals, Cancer Research UK, Newcastle University, biotech, drugs, pharma, pharmaceutical
Cancer Research UK and Newcastle University have announced that their existing research collaboration with Astex Pharmaceuticals will be extended for …
New personalised molecular blood test could shake up cancer treatment
August 16, 2017Research and Development Cancer, life sciences, medicine, pharma, pharmaceutical, standford university
A team of researchers at Stanford University have engineered a new, highly-sensitive molecular test to detect and monitor cancer which …
Massive increase in UK care home places needed by 2025, report finds
August 16, 2017Research and Development UK, UK government, biotech, drugs, pharma, pharmaceutical, social care
A study emerging from Newcastle University has pointed towards a potential crisis in care home places by 2025, as a …
BMS left red-faced as Opdivo+Yervoy fails to beat rival Pfizer drug in kidney cancer
August 16, 2017Research and Development BMS, Kidney cancer, Yervoy, life sciences, opdivo, pharma, pharmaceutical
Bristol-Myers Squibb has been left somewhat red-faced after its combination of Opdivo (nivolumab) and Yervoy (ipilimumab) failed to show any …
Less sleep in children linked to increased risk of diabetes
August 16, 2017Research and Development biotech, diabetes, drugs, pharma, pharmaceutical, type 2, type-2
A study emerging from St George’s University of London found that children who slept an hour less than the recommended …
Mending broken hearts with an injectable patch
August 16, 2017Research and Development biotech, cardiovascular, drugs, heart disease, pharma, pharmaceutical
A team of researchers from the University of Toronto have confronted a problem that had previously had no solution – …
Novo Nordisk reshuffles Executive Management team with two major additions
August 15, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, appointment, life sciences, medicine, pharma, pharmaceutical
This month has seen two new additions to Novo Nordisk’s Executive Management team. First of the pair is Camila Sylvest, …
Shire submits dry-eye drug for marketing approval
August 15, 2017Manufacturing and Production, Sales and Marketing Shire, biotech, drugs, pharma, pharmaceutical
Shire has announced that it has submitted its dry-eye drug, lifitegrast, for European marketing approval. The filing comes after it …
Gilead set to open $250m, 23-acre campus
August 15, 2017Manufacturing and Production Gilead, biotech, drugs, pharma, pharmaceutical
Gilead is set for the grand unveiling of its new facility in La Verne, Southern California, after several years of …
Regeneron abandons respiratory syncytial virus therapy after late-stage failure
August 15, 2017Manufacturing and Production, Research and Development RSV, Regeneron, pharma, pharmaceuticals, respiratory syncytial virus
Regeneron has announced that the failure of suptavumab, its experimental treatment for respiratory syncytial virus (RSV), in late-stage trials, the …
Mundipharma agrees $250m ‘smart chemotherapy’ deal
August 15, 2017Manufacturing and Production, Sales and Marketing CellAct, Mundipharma, biotech, drugs, pharma, pharmaceutical
A small biotech that has been working on developing one treatment for the last decade has finally seen the fruits …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
